Total planned funding: $600,097,831
Clear active filters
Chemonics International
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $134,789,988 |
Tanzania | $121,603,235 |
Zambia | $112,215,833 |
Mozambique | $55,580,018 |
Zimbabwe | $33,636,684 |
Rwanda | $27,441,069 |
Democratic Republic of the Congo | $19,787,449 |
Ethiopia | $16,825,781 |
Uganda | $16,222,162 |
Haiti | $12,429,765 |
Vietnam | $8,968,876 |
South Africa | $8,076,885 |
Ukraine | $6,348,771 |
Eswatini | $6,121,278 |
Kenya | $4,688,423 |
Lesotho | $2,000,000 |
Burundi | $1,815,830 |
Cameroon | $1,594,192 |
Namibia | $1,460,800 |
Botswana | $1,367,945 |
Indonesia | $1,300,000 |
Angola | $1,250,000 |
Ghana | $1,010,959 |
Central America Region | $921,400 |
South Sudan | $691,359 |
Malawi | $586,468 |
Caribbean Region | $512,660 |
Burma | $500,000 |
Cambodia | $350,000 |
Côte d'Ivoire | $1 |
Organizational Types
Private Contractor | $600,097,831 |
Program Areas
Treatment | $442,496,563 |
Testing | $54,411,122 |
Care | $42,462,116 |
Governance and Systems | $30,921,980 |
Prevention | $29,806,050 |
Budget Codes
HTXD: Treatment: ARV Drugs | $326,180,308 |
HTXS: Treatment: Adult Treatment | $106,698,890 |
HVCT: Testing: HIV Testing and Counseling | $54,411,122 |
OHSS: Health Systems Strengthening | $25,851,007 |
HBHC: Care: Adult Care and Support | $22,358,497 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $14,339,309 |
HVTB: Care: TB/HIV | $13,733,907 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $11,455,569 |
PDTX: Treatment: Pediatric Treatment | $9,617,365 |
HLAB: Laboratory Infrastructure | $3,676,137 |
HKID: Care: Orphans and Vulnerable Children | $3,405,281 |
PDCS: Care: Pediatric Care and Support | $2,964,431 |
HVOP: Sexual Prevention: Other Sexual Prevention | $1,778,015 |
HVSI: Strategic Information | $1,394,836 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $1,138,157 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $820,000 |
HMIN: Biomedical Prevention: Injection Safety | $275,000 |
HMBL: Biomedical Prevention: Blood Safety | $0 |
Top Partner Programs
Chemonics International:
$600,097,831
View countries